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Abstract  
 The present review article brings current understanding of the 
relationship between vitamin D, depression and addiction. An overview of 
vitamin D was introduced. Depression was described in details. Addiction 
was also reviewed in details. Although the relationship between vitamin D 
and depression is controversial, but it seems that a minimal concentration of 
vitamin D is required to overcome depression. Taken together, this study 
collected appropriate literature to cover various parts of the topics. 
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Vitamin D Overview 
    There are two forms including vitamin D2 (ergocalciferol), which is 
derived from plants and often added to foods, on the other vitamin D3 
(cholecalciferol) is synthesized from 7-dehydrocholesterol in the skin (Ross 
et al., 2010). Various studies have indicated that D2 and D3 to be 
functionally equivalent, and the difference is that vitamin D2 is less stable 
than D3, at least in animal studies (Ross et al., 2010). 
     Once in the circulation, either form of vitamin D is hydroxylated to 
25(OH) D in the liver and then by 1-alpha-hydroxylase in the kidney, which 
results in 1,25(OH)2D, known as calcitriol. Unlike 25(OH)D levels that vary 
markedly depending on dietary intake and sun exposure, 1,25(OH)2D levels 
are tightly regulated (Ross et al., 2010). 
    Vitamin D deficiency has prevalence rate from one third to one half 
of adults (Hoogendijk et al., 2008). The deficiency of vitamin D has been 
traditionally linked to musculoskeletal disorders and then the situation has 
been expanded to be included in optimal functioning of many body organs 
and tissues (DeLuca , 2004; Holick, 2004) . 
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Vitamin D deficiency and Depression 
 The relationship between vitamin D and depression has been 
investigated in several studies. Wilkins et al (2006) examined a group of 
elderly subjects and found mean Vitamin D levels of 18.6 nM/L, with 58% 
of subjects being frankly deficient, defined as a level below 20 nM/L. 
furthermore, low vitamin D was robustly associated with the presence of 
mood disorder (odds ratio 11.7, 95% CI 2.0–66.9). In his study, Armstrong 
et al (2006) found that Vitamin D deficiency to be associated with depression 
and anxiety in a cohort of individuals with fibromyalgia. Schneider et al 
(2000) found lower levels of 25-hydroxyvitamin D3 and 1,25-
dihydroxyvitamin D in patients with schizophrenia (N = 34), depression (N = 
25) and alcoholism (N = 30) compared to healthy controls (N = 31). In 
another study, Gloth et al (1999) conducted a study and randomized eight 
subjects with seasonal affective disorder to receive 100,000 IU of vitamin D 
and seven subjects to receive phototherapy. Results indicated that vitamin D, 
but not phototherapy was associated with improvement in depression 
measures. 
 
Depression 
    Depression, as defined by Salmans and Sandra (1997), is a condition 
or state characterized by low mood and aversion to activity that can affect a 
person's thoughts, behavior, feelings and sense of well-being.  
    There are many depressive feeling including sadness, anxious, , 
empty, hopeless, worried, helpless, worthless, guilty, irritable, hurt, or 
restless. Furthermore, depressed people may lose interest in activities that 
once were pleasurable, loss of appetite or overeating, have problems 
concentrating, remembering details, or making decisions, and may 
contemplate, attempt, or commit suicide. Insomnia, excessive sleeping, 
fatigue, loss of energy, or aches, pains, or digestive problems may also be 
present (NIMH, 2012). Depressed mood is not always due to psychiatric 
diseases. It may also be a normal reaction to certain life events, a symptom 
of some medical conditions, or a side effect of some drugs or medical 
treatments. Depressed mood is also a primary or associated feature of certain 
psychiatric syndromes such as clinical depression (NIMH, 2012).. 
 
Causes of depression 
Life events 
 Life events and changes that may lead to depressed mood include 
childbirth, menopause, financial difficulties, job problems, a medical 
diagnosis (cancer, HIV, etc.), bullying, loss of a loved one, natural disasters, 
social isolation, relationship troubles, jealousy, separation, and catastrophic 
injury (Schmidt and Peter, 2005;  Rashid and  Heider, 2008).  
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    Traumatizing events that took place in childhood can cause 
depression. Although childhood trauma and particularly child sex abuse is 
not always a factor of adulthood depression, it may create psychological 
pathways that can lead to depression. Research has been done in this field to 
demonstrate the chemical involvements explaining this phenomenon 
(Jonathan, 2003; Christine et al., 2008). According to the study of Pillemer et 
al (2010), one of the risk factors for depression is unequal treatment of 
parents. 
 
Medical treatments 
 It has been noted that there are certain medications that have the 
ability to induce depressed mood in a significant number of patients 
including interferon therapy for hepatitis C (Ehret and Sobieraj, 2014).  
 
Non-psychiatric illnesses 
    Depressed mood has been shown to be caused by a number of 
infectious diseases, neurological conditions (Murray, Buttner, Price, 2012) 
and physiological problems including hypoandrogenism (in men), Addison's 
disease, Lyme disease, multiple sclerosis, chronic pain, stroke (Saravane et 
al., 2009), diabetes (Rustad, Musselman, Nemeroff, 2011), cancer, sleep 
apnea, and disturbed circadian rhythm (Fitzgerald and Rodin, 2012).  
 
Psychiatric syndromes 
    A group of psychiatric syndromes are known to attribute to depressed 
mood as a main symptom and include major depressive disorder (MDD; 
commonly called major depression or clinical depression) in which a person 
has at least two weeks of depressed mood or a loss of interest or pleasure in 
nearly all activities; and dysthymia, a state of chronic depressed mood, the 
symptoms of which do not meet the severity of a major depressive episode. 
Another mood disorder, bipolar disorder, features one or more episodes of 
abnormally elevated mood, cognition and energy levels, but may also 
involve one or more depressive episodes (American Psychiatric Association, 
2000;  Gabbard and Glen, 2005; Vieweg et al., 2006). It is worth mentioning 
that if the course of depressive episodes follows a seasonal pattern, the 
disorder (major depressive disorder, bipolar disorder, etc.) may be described 
as a seasonal affective disorder. 
 
Assessment 
    Depression or the severity of its symptoms can be measured through 
certain tools for assessment including the Beck Depression Inventory and 
Children's Depression Inventory test for depression and/or depressive 
symptoms (Kovacs, 1992).  
European Scientific Journal   August  2014 edition vol.10, No.24   ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
134 
Treatment 
 In general, depressed mood may not need professional treatment 
since it may reflect a normal reaction to certain life events, a symptom of 
some medical conditions, or a side effect of some drugs or medical 
treatments. In case there is a prolonged depressed mood, particularly in 
combination with other symptoms, which may lead to a diagnosis of a 
psychiatric or medical condition so that patients can benefit from treatment 
(Cheog, 2014).  
    According to a study of Khan et al (2012), it is important to reach an 
accurate diagnosis of major depressive disorder to initiate the treatment. 
Furthermore, Craft and  Perna (2004) reported that moderate levels of 
physical activity can treat depression by increasing the levels of endorphins 
and the neurotransmitters serotonin, dopamine, and norepinephrine. 
Furthermore, it has been indicated that exercise improves the health of 
individuals while building new relationships with others and bolstering the 
sense of community that comes with exercising as a group (Skrinar et al., 
1992; Pelham and Campagna, 1993). The authors have also expressed their 
observations in which group activities can reduce depression by increasing 
depressed individuals’ ability to interact with others. Exercise has also been 
found to increase individuals’ self-confidence by encouraging social skills 
that people with depression often lack and interrupts the cycle of isolation 
from the general population that can further increase depression. Exercise 
has another advantage in which it fosters non-demanding behaviors while 
allowing people to socialize and identify themselves as part of the general 
population (Skrinar et al., 1992; Pelham and Campagna, 1993). 
 Depression can also be treated through lifestyle strategies that may 
improve depressed mood include wake therapy, light therapy, eating a 
healthy diet, meditation, exercise, and smoking cessation (Praschak-Rieder et 
al., 1999; Even et al., 2008; Madhav et al., 2014; Taylor et al., 2014).  
 
Social 
    According to Podgornik (2012), women are generally more likely to 
have depression which is plausible to due to gender roles and norms 
associated with those roles. Women are expected and required to care for 
family and friends, but they lack strong, stable supportive relationships and 
accordingly they are more susceptible to depressive symptoms.  
 
Addiction 
    Addiction can be defined as the continued repetition of a behavior 
despite adverse consequences, or a neurological impairment leading to such 
behaviors (Angres and  Bettinardi-Angres, 2008; American Society for 
Addiction Medicine, 2012 ).  
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 Addictions are widely classified and can include drug abuse, exercise 
addiction, food addiction, computer addiction and gambling. Classic 
characteristics of addiction include impaired control over substances or 
behavior, preoccupation with substance or behavior, continued use despite 
consequences, and denial (Morse and Flavin, 1992). Habits and patterns 
associated with addiction are typically characterized by immediate 
satisfaction (short-term reward), coupled with delayed deleterious effects 
(long-term costs) (Marlatt et al., 1998).  
    According to Torres and Horowitz (1999), physiological dependence 
occurs when the body has to adjust to the substance by incorporating the 
substance into its "normal" functioning. This state creates the conditions of 
tolerance and withdrawal. Tolerance is the process by which the body 
continually adapts to the substance and requires increasingly larger amounts 
to achieve the original effects. Withdrawal refers to physical and 
psychological symptoms experienced when reducing or discontinuing a 
substance that the body has become dependent on. Symptoms of withdrawal 
generally include but are not limited to anxiety, irritability, intense cravings 
for the substance, nausea, hallucinations, headaches, cold sweats, and 
tremors. 
 
Biological mechanisms explaining addiction 
    Various studies agree about the biological mechanisms are present 
beyond addiction. It has been indicated that many variables are present, but 
researchers expressed variations about among which are the primary 
contributing factors. There has been a debate in which the biological "nature" 
of individual innate qualities can be in relation for many decisions and 
actions, such as a family history in which genetics, DNA, and other mental 
disorders remain latent for generations and then are triggered (Tsuang et al., 
1998).  
    The risk of a future addictive disorder has been suggested to greatly 
increase if an individual gets exposed to repeated stress or engages in drug 
abuse during adolescence due to it being a critical neuro-developmental stage 
which is sensitive to such experiences or insults. The reason that stress and 
substance abuse during adolescence increases the risk of addiction is due to 
the changes it does to the brain (Crews and Vetreno, 2011). 
 It has been shown that Several brain regions are also involved in the 
biological mechanisms of addiction. Most notably, the release of dopamine 
into the nucleus accumbens, which is triggered by a wide variety of drugs in 
a wide variety of ways, plays a role in the reinforcing qualities of stimuli 
(Salamone, 1992). It has been suggested to have a role for dopamine because 
its secretion is also characteristic of natural reinforcing stimuli such as food, 
water, and sex. Accordingly, it's evident that the addictive nature of drug 
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involves processes that capture these mechanisms. Furthermore, it has been 
found that this process begins in the limbic dopaminergic system and 
subsequently modifies other parts of the brain that receive input from the 
affected neurons. Among these areas is the ventral tegmental area (Kauer and 
Malenka, 2007). 
    Belin and Everitt (2008) clarified some biological mechanisms 
including the insertion of extra α-Amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors into the postsynaptic membrane 
of the DA neurons. Studies conducted in mice indicate that exposure to 
cocaine for two weeks can cause long-term changes in the ventral tegmental 
area. They also found that the pleasurable effects of the drug reinforce the 
behaviors associated with acquiring and ingesting the drug until they become 
a habit. Early on, this process takes place largely in the ventral striatum, 
specifically in the nucleus accumbens but eventually, these changes 
primarily involve the dorsal striatum. Further studies suggest that the 
neuronal modifications involved in addiction follow a dorsally cascading 
sequence of reciprocal connections between the two aforementioned areas. 
    Various studies have targeted the changes that happen in the 
nucleus accumbens and in the dorsal striatum including alterations in the 
dopamine receptors on the neurons which send axons to other areas. 
Dopamine D1 receptors were found to increase which, in turn, results in 
excitation and facilitation of behavior. On the other hand, dopamine D2 
receptors were found to lessen, resulting in inhibited and suppressed 
behavior. It has been found that certain drug use has the ability to affect 
acetylcholinergic interneurons which, though few in number, exert their 
influence on medium spiny neurons in the nucleus accumbens (Witten, Lin, 
Brodsky, 2010). In conclusion, the release of dopamine in the nucleus 
accumbens results in the early stages of drug addiction. It has been shown 
that subsequent impairments in regions such as the dorsal striatum attribute 
to the formation of actual drug-taking habitual behaviors. According to this 
context, it is possible to explain why drug addicts are prompted to obtain the 
drug and consume it when environmental cues associated with drug-taking 
are present but become withdrawn and sad when participating in drug-free 
activity (Volkow, Wang, Fowler, 2011). 
    According to a study of Tarter et al (2003),  regarding to initial use 
and drug addiction, different factors can play a role in determining one's 
predisposition. Furthermore, the prefrontal cortex, which has bearing on 
judgement, risk taking, and impulse control, may be complicit in explaining 
why adolescents are more prone to drug-taking behavior. In fact, some 
studies have demonstrated that children, as young as ten to twelve years old, 
who score lowest on measures of behavioral inhibition displayed the highest 
risks of developing substance addiction. 
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The Relationship between Vitamin D and Depressive Disorders 
    As previously mentioned, the seasonal changes of  vitamin D and the 
numerous CNS actions of calcitriol make vitamin D a key player to explain 
seasonal mental health problems. 
    Several  studies across literature have investigated the relationship 
between SAD and phototherapy and raised the question of light wavelength 
and the proposed role of vitamin D. The studies reached to conclusions that 
UV light does not have that efficacy in addition to the noninvolvement of 
vitamin D (Oren, Schulkin, Rosenthal, 1994; Lee et al., 1997). According to 
this context, phototherapy research worked to filter UV light away and 
because the patients may be fully covered which leads to formation of 
negligible amounts of vitamin D (Partonen et al., 1996). 
    Lansdowne and Provost (1998) conducted a double-blind study and 
found that vitamin D3 led to a more positive mood in healthy individuals 
during winter. In another study by Gloth 3rd, Aalam, and Hollis (1999) in 
which the authors compared vitamin D and light therapy, the results showed 
that among  15 SAD patients, 100,000 IU of vitamin D was more effective 
than 3 weeks of light therapy. The reduction of depression was explained by 
increasing of 25-OHD. These findings were on line with another study 
conducted by Shipowick et al (2009) who studied six patients, treated in 
winter with vitamin D 5000 IE/day. The results showed that among the 6 
patients, 3 patient reached a final vitamin D level above 100 nmol/l 
responded while the others did not. The results of other two larger studies did 
not prove the efficacy of vitamin D, and this is expected to be resulted from 
using lower doses of vitamin D (400–800 IE/day). Accordingly, it is 
plausible to think that  participants were  unlikely  to reach the necessary 
blood levels (Harris and Dawson-Hughes, 1993; Dumville et al., 2006). Two 
European studies proved the relation between lower levels of vitamin D and 
depressed mood irrespective of season (Jorde et al., 2006). On the other 
hand, a study on Chinese population did not support the relationship between 
vitamin D and depression (Pan et al., 200).   
 The results of 4 clinical studies on patients diagnostic with 
psychiatric diseases, including major depression indicated that vitamin D 
levels in general were lower than control groups  with similar range 
(mean/median 40–50 nmol/l) for depressed patients (Berk et al., 2007, 2008;  
Schneider  et al., 2007; Humble, Gustafsson, Bejero, 2010).  
 Taken together, the previous findings gave a support, but did not 
confirm the hypothesis that low availability of vitamin D could cause a 
substantial proportion of depressive disorders. 
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